Case Note & Summary
The case pertains to an appeal filed by the Pr. Commissioner of Income Tax 2 under Section 260A of the Income Tax Act, 1961, against an order of the Income Tax Appellate Tribunal, Mumbai Bench 'A', dated 25.1.2017, for the assessment year 2006-07. The respondent, M/s. Aristo Pharmaceuticals P Ltd, is a pharmaceutical company. The core dispute involved the applicability of Fringe Benefit Tax (FBT) on free medical samples distributed by the respondent to doctors. The Assessing Officer (AO) had levied FBT on such samples, treating them as a fringe benefit under Section 115WB of the Act. The Tribunal, however, set aside the AO's action, holding that free medical samples do not fall within the definition of fringe benefits. The Revenue appealed, raising two substantial questions of law: (i) whether the Tribunal was right in setting aside the AO's action without appreciating that the fringe benefit assessment was framed after considering CBDT Circular No. 8/2005 and the Explanatory Notes to the Finance Act, 2005; and (ii) whether the Tribunal was right in ignoring the Supreme Court's decision in ESkayef Ltd., 245 ITR 116, which allegedly held that free medical samples distributed to doctors are in the nature of sales promotion and thus liable to FBT. The High Court examined the provisions of Chapter XXII-H of the Act, particularly Section 115WB, which defines fringe benefits. It noted that the definition does not include free medical samples. The Court also considered the CBDT Circular and Explanatory Notes, which did not support the Revenue's interpretation. Regarding the ESkayef case, the Court observed that it dealt with a different context and did not directly address the issue of FBT on free samples. Consequently, the High Court dismissed the appeal, holding that no substantial question of law arose. The decision upheld the Tribunal's order, confirming that free medical samples are not fringe benefits under the Act.
Headnote
A) Income Tax - Fringe Benefit Tax - Free Medical Samples - Section 115WB, Income Tax Act, 1961 - The issue was whether free medical samples distributed by a pharmaceutical company to doctors constitute a fringe benefit under Section 115WB. The Tribunal held that such samples are not fringe benefits as they are not covered under any of the clauses of Section 115WB. The High Court upheld this view, noting that the CBDT Circular No. 8/2005 and Explanatory Notes to the Finance Act, 2005 do not support the Revenue's contention. Held that free medical samples are not fringe benefits (Paras 4-6).
Issue of Consideration
Whether free medical samples distributed to doctors fall within the definition of fringe benefits under Section 115WB of the Income Tax Act, 1961, and are thus liable to Fringe Benefit Tax.
Final Decision
Appeal dismissed. No substantial question of law arises. Tribunal's order upheld.
Law Points
- Fringe Benefit Tax
- Free medical samples
- Sales promotion
- Section 115WB
- CBDT Circular No. 8/2005
